Pharmaceuticals

Caught in deadly race with new COVID strain, Britain 'gambles' with mix-and-match vaccine regimen

Scientists have slammed the new guidance which allows for the interchange of vaccines, if the second dose of the vaccine originally received is not available, saying officials have abandoned science and are just trying to 'guess their way out of a mess'

MIT researchers create gel that mimics camel fur, could help keep objects cool for days

Tests have shown that this new gel, which is less than half-inch thick, can provide cooling of more than sever degrees Celsius for five times longer than hydrogel alone.

India pledges $15-mn at virtual global vaccine summit; funds to be used for immunisation programmes across the world

Prime Minister Narendra Modi on Thursday pledged $15-million as India's contribution to the vaccines alliance GAVI at the Global Vaccine Summit hosted by the UK

Lupin Q4 results: Consolidated net profit rises 35% to Rs 390 cr; income from operations marginally down

Drug firm Lupin has reported a 34.55 percent rise in its consolidated net profit to Rs 389.63 crore for the quarter ended March 2020 mainly on account of robust sales in the domestic market and lower tax expenses

Lupin gets inspection closure report from USFDA for Pithampur manufacturing plant in Madhya Pradesh

Drug maker Lupin on Thursday said the US health regulator has closed the inspection of its manufacturing facility in Pithampur, Madhya Pradesh

Coronavirus outbreak highlighted vulnerabilities in medical manufacturing supply chain: Fitch Solutions

With pharmaceutical supply chains under immense pressure due to COVID-19, China's role as a global ingredient producer has come under scrutiny, Fitch Solutions has said

Lupin's Mandideep Unit II facility in Madhya Pradesh receives EIR from USFDA

Pharma major Lupin on Wednesday said it has received an establishment inspection report (EIR) from the US health regulator for its Mandideep Unit II facility in Madhya Pradesh

Lupin gets EIR from USFDA for Nagpur plant; MD says committed to enhance compliance, quality standards at all sites

Drug maker Lupin on Monday said it has received an Establishment Inspection Report (EIR) from the US health regulator for its manufacturing plant in Nagpur

Coronavirus Outbreak: The story of a premier US pharma company that became a COVID-19 'super spreader'

On the first Monday in March, Michel Vounatsos, chief executive of the drug company Biogen, appeared in good spirits. The company’s new Alzheimer’s drug was showing promise after years of setbacks. Revenues had never been higher

Tussle over hydroxychloroquine puts India's neighbourhood first policy at odds with efforts to appease Trump

On Tuesday, India lifted an export ban on 24 active pharmaceutical ingredients, believed to be critical in the battle against coronavirus